Kingymab: The Monoclonal Antibody for RSV Prevention
Respiratory syncytial virus (RSV) is a common virus that infects nearly all children by the age of two. While most RSV infections are mild, some infants and young children experience severe symptoms that require hospitalization. Kingymab is a medication that has the potential to help prevent these severe RSV infections. What is Kingymab? Kingymab is